Quidel | QDEL - 税前利润



金融业
股票价格
USD
资产
USD 5.72B
现金及等价物
USD 123.4M
销售成本
USD 407M
流动资产
USD 1.38B
流动负债
USD 993.4M
债务
USD 2.87B
EBIT
USD -15.3M
EBITDA
USD 129.3M
员工
6.6K
EPS每股收益
USD -1.27
股本和储备
USD 1.85B
销售毛利
USD 223.9M
债务利息支出
USD 5.63B
利息收入
USD -1.35
贷款资金
USD 2.54B
市值
USD 714.6M
净收入
USD -92.9M
营业费用
USD 646.2M
营业利润
USD -15.3M
普通股股本
USD 68.1M
PE价格收益
2.03
税前利润
USD -79.5M
销售收入
USD 630.9M
销售和管理费用
USD 189.7M
股票
USD 618.9M
贸易债权人
USD 236.5M
应收帐款人
USD 352M


税前利润 更改 日
Abbott USD 2.39B 27M 2026-03
Agilent USD 408M 44M 2026-03
Becton, Dickinson and Co. USD 39M 354M 2026-03
Bruker USD 117M 95.1M 2026-06
Cerus USD -20.76M 17.9M 2024-12
Charles River Laboratories USD -29.94M 264.16M 2026-03
Danaher USD 1.08B 157M 2026-06
Haemonetics USD 47.57M 75.97M 2026-06
Illumina USD 260M 103M 2026-06
IQVIA Holdings USD 301M 5.92B 2026-06
Merit Medical Systems USD 53.55M 2.49M 2026-03
Mettler Toledo International USD 209.66M 119.42M 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
Neogen USD -20.3M 48.3M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Quidel USD -79.5M 32.9M 2026-03
Revvity USD 187.24M 137.25M 2026-06
STAAR Surgical USD 8.22M 28.87M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Waters USD 356M 444M 2026-06